Adlai Nortye Ltd ADR (ANL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ANL | KYTX | CTKB | ||
| Company | Adlai Nortye Ltd ADR | Kyverna Therapeutics Inc | Cytek Biosciences Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 14.00 | 9.60 | 4.71 | ||
| High | 16.97 | 10.03 | 4.73 | ||
| Low | 13.20 | 9.55 | 4.56 | ||
| Latest | 16.01 | 9.93 | 4.61 | ||
| Change | +2.32 | +0.40 | unch | ||
| % Change | +16.95% | +4.20% | unch | ||
| Volume | 1,387,300 | 919,500 | 578,500 | ||
| 20-Day Average Volume | 556,125 | 723,625 | 601,205 | ||
| Previous Close | 13.69 | 9.53 | 4.61 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 9.80 | 8.74 | 4.55 | ||
| 20-Day Raw Stochastic | 90.93% | 96.28% | 63.64% | ||
| 20-Day Relative Strength | 71.18 | 60.39 | 52.57 | ||
| Weighted Alpha | +80.41 | +156.58 | +25.54 | ||
| Today's Opinion | 100% Buy | 96% Buy | 40% Buy | ||
| Previous Opinion | 100% Buy | 88% Buy | 40% Buy | ||
| Last Month's Opinion | 72% Buy | 100% Buy | 8% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +43.46% since 04/10/26 | +10.95% since 04/10/26 | +1.77% since 04/10/26 | ||
| Low | 7.20 on 04/15/26 | 8.90 on 04/13/26 | 4.51 on 04/13/26 | ||
| High | 16.97 on 04/17/26 | 10.03 on 04/17/26 | 4.73 on 04/17/26 | ||
| 1-Month | |||||
| %Chg | +99.63% since 03/17/26 | +12.84% since 03/17/26 | +8.47% since 03/17/26 | ||
| Low | 6.34 on 03/30/26 | 7.34 on 03/30/26 | 4.19 on 03/30/26 | ||
| High | 16.97 on 04/17/26 | 10.03 on 04/17/26 | 4.85 on 04/08/26 | ||
| 3-Month | |||||
| %Chg | +789.44% since 01/16/26 | +18.78% since 01/16/26 | -14.63% since 01/16/26 | ||
| Low | 1.63 on 01/20/26 | 7.21 on 02/05/26 | 3.95 on 03/13/26 | ||
| High | 16.97 on 04/17/26 | 10.55 on 01/22/26 | 5.70 on 01/22/26 | ||
| 6-Month | |||||
| %Chg | +876.22% since 10/17/25 | +49.77% since 10/17/25 | +16.71% since 10/17/25 | ||
| Low | 0.88 on 12/09/25 | 6.20 on 11/07/25 | 3.70 on 10/31/25 | ||
| High | 16.97 on 04/17/26 | 13.67 on 12/15/25 | 6.18 on 11/17/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 590,769 | 601,063 | 589,458 | ||
| Shares Outstanding, K | 36,900 | 60,530 | 127,865 | ||
| Annual Sales | 5,000,000 | 0 | 201,490,000 | ||
| Annual Net Income | -35,530,000 | -161,310,000 | -66,540,000 | ||
| Last Quarter Sales | 0 | 0 | 62,140,000 | ||
| Last Quarter Net Income | -63,397,000 | -37,800,000 | -44,080,000 | ||
| 60-Month Beta | -0.76 | 2.62 | 1.28 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A on 09/29/23 | -0.80 on 03/26/26 | -0.01 on 02/26/26 | ||
| Latest Earnings Date | 04/29/26 | 05/12/26 | 05/14/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||